ReliOx Corporation

About ReliOx Corporation

ReliOx Corporation is a Jacksonville, Florida biotechnology company developing a patented, resin mediated, on demand aqueous chlorine dioxide platform. The technology originated from University of Florida research and underlies four product lines: Whiff!, a consumer and commercial odor elimination and hygienic cleaning product; WhiffPRO, a commercial grade version; VetiOx, for veterinary use; and Debrinse, a wound irrigation device currently in development. ReliOx holds six issued U.S. patents and is pursuing applications across healthcare hygiene, veterinary care, food safety, and other markets, with several regulatory and research initiatives in progress.

What differentiates you from the competition?

Our patented chlorine dioxide platform generates output on demand with no acid activation step, supported by independent laboratory validation data.

What are your top selling services or products that your company offers?

A single core chemistry underlies our full product line, offering pH neutral, resin generated chlorine dioxide without a harsh acid activation step, currently in active development and evaluation across several use cases.

If you had one message to get across to future customers, what would it be?

ReliOx is building a scalable, science backed disinfection technology platform, and we are committed to transparency as our products and approvals continue to advance.

What is the biggest marketing challenge that you will face in the upcoming year?

Communicating a novel disinfection chemistry clearly to different audiences while our regulatory approvals and research partnerships vary greatly and many remain in progress, without overstating each initiative.